dc.contributor.author | Iravani, Mahmoud M. | |
dc.contributor.author | Sadeghian, Mona | |
dc.contributor.author | Leung, Clement C. M. | |
dc.contributor.author | Jenner, Peter | |
dc.contributor.author | Rose, Sarah | |
dc.date.accessioned | 2013-02-04T14:30:29Z | |
dc.date.available | 2013-02-04T14:30:29Z | |
dc.date.issued | 2012-02-29 | |
dc.identifier.citation | Iravani , M M , Sadeghian , M , Leung , C C M , Jenner , P & Rose , S 2012 , ' Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor. ' , Neuroscience Letters , vol. 510 , no. 2 , pp. 138-142 . https://doi.org/10.1016/j.neulet.2012.01.022 | |
dc.identifier.issn | 0304-3940 | |
dc.identifier.other | ORCID: /0000-0002-4905-9682/work/32997571 | |
dc.identifier.uri | http://hdl.handle.net/2299/9824 | |
dc.description.abstract | Reactive gliosis and inflammatory change is a key component of nigral dopaminergic cell death in Parkinson's disease (PD). Astrocyte derived glial cell line-derived neurotrophic factor (GDNF) promotes the survival and growth of dopaminergic neurones and it protects against or reverses nigral degeneration induced by 6-OHDA and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rodents and primates. But the effect of increased levels of pro-inflammatory cytokines on the release of GDNF is unknown. This study examined the relationship between release of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) and the expression of GDNF in rats following nigral lipopolysaccharide (LPS) administration. Acute nigral administration of LPS led to marked elevation of IL-1 beta but insignificant INF-cs tissue content and to a prominent expression of GDNF immunoreactivity in astrocytes but not microglia. The results suggest that inflammation is not only involved in neuronal loss but could promote neuronal survival through increased release of GDNF following up-regulation of IL-1 beta. (C) 2012 Elsevier Ireland Ltd. All rights reserved. | en |
dc.format.extent | 5 | |
dc.format.extent | 785965 | |
dc.language.iso | eng | |
dc.relation.ispartof | Neuroscience Letters | |
dc.subject | Substantia nigra | |
dc.subject | NEURODEGENERATIVE DISEASE | |
dc.subject | NECROSIS-FACTOR-ALPHA | |
dc.subject | Astrocytes | |
dc.subject | PARKINSONS-DISEASE | |
dc.subject | REACTIVE ASTROCYTES | |
dc.subject | Lipopolysaccharide (LPS) | |
dc.subject | MOUSE MODEL | |
dc.subject | NITRIC-OXIDE | |
dc.subject | Tumour necrosis factor-alpha (TNF-alpha) | |
dc.subject | NIGROSTRIATAL DOPAMINERGIC SYSTEM | |
dc.subject | GDNF MESSENGER-RNA | |
dc.subject | SUBSTANTIA-NIGRA | |
dc.subject | Interleukin-1 beta (IL-1 beta) | |
dc.subject | RAT STRIATUM | |
dc.subject | Glial cell line-derived neurotrophic factor (GDNF) | |
dc.title | Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor. | en |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Centre for Research in Mechanisms of Disease and Drug Discovery | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.contributor.institution | Basic and Clinical Science Unit | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1016/j.neulet.2012.01.022 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |